Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4:30 p.m. Eastern Time
26 Juillet 2022 - 10:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS) a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced that it plans to release
its second quarter 2022 financial results after market close on
Tuesday, August 9, 2022.
Management will hold a conference call to review the Company’s
second quarter 2022 performance starting at 4:30 p.m. (Eastern
Time) on the same day. The conference call will be concurrently
webcast. The link to the webcast will be available on Senseonics
Holdings, Inc. website at www.senseonics.com by navigating to
“Investor Relations,” and then “Events & Publications,” and
will be archived there for future reference. To listen to the
conference call, please dial 1-888-317-6003 (US/Canada) or
1-412-317-6061 (International), passcode 3659816, approximately ten
to five minutes prior to start time.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company
focused on the development and manufacturing of glucose monitoring
products designed to transform lives in the global diabetes
community with differentiated, long-term implantable glucose
management technology. Senseonics' CGM systems, Eversense®,
Eversense® XL and Eversense® E3 include a small sensor inserted
completely under the skin that communicates with a smart
transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220726006069/en/
Senseonics Investor Contact Philip Taylor Investor
Relations 415-937-5406 investors@senseonics.com
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Oct 2023 à Nov 2023
Senseonics (AMEX:SENS)
Graphique Historique de l'Action
De Nov 2022 à Nov 2023